BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31569928)

  • 1. Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer.
    Lukianova NY; Borikun TV; Chekhun VF
    Exp Oncol; 2019 Sep; 41(3):242-247. PubMed ID: 31569928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
    Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
    Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIMP-3 mRNA expression levels positively correlates with levels of miR-21 in in situ BC and negatively in PR positive invasive BC.
    Petrovic N; Sami A; Martinovic J; Zaric M; Nakashidze I; Lukic S; Jovanovic-Cupic S
    Pathol Res Pract; 2017 Oct; 213(10):1264-1270. PubMed ID: 28935174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer.
    Gong C; Tan W; Chen K; You N; Zhu S; Liang G; Xie X; Li Q; Zeng Y; Ouyang N; Li Z; Zeng M; Zhuang S; Lau WY; Liu Q; Yin D; Wang X; Su F; Song E
    EBioMedicine; 2016 Sep; 11():199-209. PubMed ID: 27566954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of CD44
    Chekhun VF; Lukianova NY; Chekhun SV; Bezdieniezhnykh NO; Zadvorniy TV; Borikun TV; Polishchuk LZ; Klyusov OМ
    Exp Oncol; 2017 Sep; 39(3):203-211. PubMed ID: 28967645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.
    Gwak JM; Kim HJ; Kim EJ; Chung YR; Yun S; Seo AN; Lee HJ; Park SY
    Breast Cancer Res Treat; 2014 Aug; 147(1):39-49. PubMed ID: 25086633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EXPRESSION PATTERN OF miR-125b-2, -155, -221, AND -320a IS ASSOCIATED WITH RESPONSE OF BREAST CANCER PATIENTS TO TAMOXIFEN.
    Pridko O; Borikun T; Rossylna O; Rishko M; Rusyn AV
    Exp Oncol; 2022 Dec; 44(4):295-299. PubMed ID: 36811533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial.
    Müller V; Gade S; Steinbach B; Loibl S; von Minckwitz G; Untch M; Schwedler K; Lübbe K; Schem C; Fasching PA; Mau C; Pantel K; Schwarzenbach H
    Breast Cancer Res Treat; 2014 Aug; 147(1):61-8. PubMed ID: 25086636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-4728-3p could act as a marker of HER2 status.
    Li H; Zhou X; Zhu J; Cheng W; Zhu W; Shu Y; Liu P
    Cancer Biomark; 2015; 15(6):807-14. PubMed ID: 26406406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of differential distribution of microvessel density, possibly regulated by miR-374a, on breast cancer prognosis.
    Li JY; Zhang Y; Zhang WH; Jia S; Kang Y; Tian R
    Asian Pac J Cancer Prev; 2013; 14(3):1715-20. PubMed ID: 23679262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low expression of miR-597 is correlated with tumor stage and poor outcome in breast cancer.
    Zhang XY; Liu DJ; Yuan RB; Zhang DH; Li SR; Zhang SH; Zhang LY
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):456-460. PubMed ID: 29424903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients.
    Hafez MM; Hassan ZK; Zekri AR; Gaber AA; Al Rejaie SS; Sayed-Ahmed MM; Al Shabanah O
    Asian Pac J Cancer Prev; 2012; 13(2):591-8. PubMed ID: 22524830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of miR-139 as a surrogate marker for tumor aggression in breast cancer.
    Dai H; Gallagher D; Schmitt S; Pessetto ZY; Fan F; Godwin AK; Tawfik O
    Hum Pathol; 2017 Mar; 61():68-77. PubMed ID: 27864119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-21 Expression in Primary Breast Cancer Tissue Among Egyptian Female Patients and its Correlation with Chromosome 17 Aneusomy.
    Abdel-Hamid NR; Mohammed EA; Abbas AH; Badr FM
    Mol Diagn Ther; 2015 Dec; 19(6):365-73. PubMed ID: 26342497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphism of miR-196a as a prognostic biomarker for early breast cancer.
    Lee SJ; Seo JW; Chae YS; Kim JG; Kang BW; Kim WW; Jung JH; Park HY; Jeong JY; Park JY
    Anticancer Res; 2014 Jun; 34(6):2943-9. PubMed ID: 24922658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
    Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
    Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Cell-free miRNA Expression and its Association with Clinicopathologic Features in Inflammatory and Non- Inflammatory Breast Cancer.
    Hamdi K; Blancato J; Goerlitz D; Islam M; Neili B; Abidi A; Gat A; Ayed FB; Chivi S; Loffredo C; Jillson I; Elgaaied AB; Marrakchi R
    Asian Pac J Cancer Prev; 2016; 17(4):1801-10. PubMed ID: 27221856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1.
    Yao Y; Hu J; Shen Z; Yao R; Liu S; Li Y; Cong H; Wang X; Qiu W; Yue L
    J Cell Mol Med; 2015 Apr; 19(4):760-9. PubMed ID: 25639535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic significance of circulating miRNAs and metabolite profiling in early prediction of breast cancer in Egyptian women.
    El-Toukhy SE; El-Daly SM; Kamel MM; Nabih HK
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):5437-5451. PubMed ID: 36459290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.